Shares of Centessa Pharmaceuticals (CNTA +43.80%) surged on Tuesday after the drugmaker struck a deal to be acquired by Eli Lilly (LLY +3.55%) for as much as $7.8 billion. An enticing offer for Centessa's investorsUnder the terms of the deal, Lilly would purchase Centessa for $38 per share in cash. That's a premium of nearly 38% to the healthcare stock's closing price on Monday.Centessa's shareholders would also receive a non-transferrable contingent value right, which could be valued at up to $9 per share ...